
Researchers at the University of Virginia Health System have uncovered a critical mechanism in the brain’s cleanup system that could transform future neurodegenerative disease treatment. The study revealed that a little-known Alzheimer’s risk gene called CASS4 operates primarily within microglia—the brain’s resident immune cells—rather than neurons. When CASS4 malfunctions, microglia fail to properly surround and contain toxic amyloid plaques, accelerating neuronal damage and cognitive decline. Restoring this immune pathway offers a promising new therapeutic target.